Urethral Squamous Cell Carcinoma
NCI Definition: A well differentiated, moderately differentiated, or poorly differentiated squamous cell carcinoma that arises from the male or female urethra. 
There are 2 clinical trials for urethral squamous cell carcinoma, of which 2 are open and 0 are completed or closed. Of the trials that contain urethral squamous cell carcinoma as an inclusion criterion, 2 are phase 2 (2 open).
Durvalumab, nivolumab, and tremelimumab are the most common interventions in urethral squamous cell carcinoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.